Dr V V S Rajendra Prasad
Professor
Vishnu Institute of Pharmaceutical Education and Research
Telangana
Expertise:
Medicinal Chemistry
35
Publications
12
Projects
348
Scopus Citations
304
CrossRef
17 Years 9 Months Total Experience
Scopus
348
Citations
11
h-index
CrossRef
304
Citations
11
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
SIPRA Innovation Award
2015
SIPRA LABS LIMITED
Career Award for Young Teachers (CAYT
2012
AICTE India
Senior Research Fellowship (SRF) by ICMR
2006
ICMR, Govt of India
Fast Track Young Scientist Award with Research Grant
2011
DST
Community & Membership
No Data Found
There is currently nothing to display here.
APTI
Life MemberIPA
Life MemberPersonal Details
Doctor of Philosophy
2008
Institute of Liver and Bilary Sciences
Master of Pharmacy
2005
N/A
Bachelor of Pharmacy
2001
N/A
Professor
Dec 2008 – Present
Vishnu Institute of Pharmaceutical Education and Research
Medical and Health Sciences
Scholarly Work
Center for Advanced Research on manufacturing of Alumina, Zirconia, Zirconia Toughened Alumina (ZTA), and Alumina Toughened Zirconia (ATZ) ceramic based Dental devices
OtherDevelopment and characterization of polymer based letrozole loaded na no particulate formulation to induce programmed cellular death in breast cancer,in vitro and invivo studies
CompletedNitric oxide releasing Quinilones derivatives as inhibitors of doxorubicine resistance in cancer
OtherDevelopment of an affordable test kit for early detection of colon cancer and GIT disorders
CompletedNitric oxide releasing acridone carboxamide derivatives as reverters of doxorubicin resistance in MCF7/Dx cancer cells
CompletedCytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies
CompletedDevelopment of an affordable test kit for early detection of colon cancer and GIT disorders
OtherNitric oxide releasing Quinilones derivatives as inhibitors of doxorubicine resistance in cancer
OtherDevelopment of Nitric oxide releasing Quinoline derivatives as inhibitors of doxorubicin resistance in cancer cells
OtherProject, structural insights to inhibit epidermal growth factor receptor (EGFR) dimerization & activation: panitumumab induced conformational study
CompletedDesign And Synthesis Of Nitric Oxide Donating acridone derivatives as reverters of multidrug resistance (MDR) in cancer cells
CompletedDesign, Synthesis of quinazoline tagged Acridones and their cytotoxic studies in drug sensitive, resistant cells
CompletedDesign And Synthesis Of Nitric Oxide Donating Acridone Derivatives As Chemosensitizing Agents In Cancer Cells
Development and Validation of Stability Indicating High Performance Liquid Chromatography Method to quantify active pharmaceutical ingredients in solid dosage forms
Design, synthesis of pyrazoles as inhibitors of aurora kinase and their cytotoxic studies in cancer cells
Design, Synthesis of quinazoline derivatives as inhibitors of jak2 and their cytotoxic studies in cancer cells
DEVELOPMENT AND VALIDATION OF NEW & IMPROVED ANALYTICAL METHODS FOR EVALUATION OF SOME ANTI CANCER & ANTI FUNGAL DRUGS AND THEIR DOSAGE FORMS BY HPLC & UpLC
A FORMULATION OF TRANSETHOSOMAL FOR TRAGETED DRUG DELIVERY AND A METHOD OF PREPARING THE SAME
Indian Institute of Technology (IIT)
Hyderabad
-
Patent No. :
572660
Filed :
20-01-2025
Published :
30-11--0001
Granted
Substituted Pyrazolopyrimidines As Her-2 And Cdk4/6 Inhibitors And Uses Thereof
Vishnu Institute of Pharmaceutical Education and Research
-
Patent No. :
571772
Filed :
13-01-2024
Published :
30-11--0001
Granted
Novel N10 - Substituted 2-Chloro Acridones, Molecular Docking, Lipophilicity And Cytotoxic Studies Against MCF–7 Cell Lines
Vishnu Institute of Pharmaceutical Education and Research
-
Application No. :
202341052682
Filed :
25-05-2023
Published :
30-11--0001
Published
Nitric Oxide Donating 5,6-Di Phenyl 1,2,4-Triazinecarbamoyl and Sulphamoyl Aryl Nitrate Derivatives As cytotoxic Agents In Cancer
Vishnu Institute of Pharmaceutical Education and Research
-
Patent No. :
483992
Filed :
25-03-2023
Published :
30-11--0001
Granted
Nitric Oxide Donating Quinazoline Fused Pyrazole Derivatives As Cytotoxic Agents in Cancer
Vishnu Institute of Pharmaceutical Education and Research
-
Patent No. :
418135
Filed :
26-04-2022
Published :
06-05-2022
Granted
Scholarly Publications
Hyaluronic-Acid-Functionalized Tofacitinib Loaded Transethosomes for Targeted Drug Delivery in Rheumatoid Arthritis
Synthesis of new thiazolidin-4-one substituted 1,2,4-triazoles as antimicrobial agents
Scopus: 1
Synthesis and evaluation of fexofenadine analogue for antihistaminic, anticholinergic and sedative activities
Scopus: 1
Development and validation of a stability indicating uplc method for determination of voriconazole in pharmaceutical formulation
Scopus: 2
Development and validation of a stability indicating uplc method for determination of erlotinib in pharmaceutical formulations
Scopus: 8
Estimation of pomalidomide in capsule dosage form by RP-HPLC
Scopus: 2
Development and validation of stability indicating UPLC method for quantification of anti oxidant in complex dosage forms
Scopus: 1
Development and validation of ultra-faststability indicating uplc method forquantification of related compounds of acetylsalicylic acid in it's solid dosage form
Showing 1 to 8 of 35 publications